This is a competing continuation application entitled ?Molecular Epidemiology of Cancer Training Program? (T32 CA09142).
The specific aims of this research training program are to continue implementing innovative, multidisciplinary, and collaborative research training in cancer epidemiology and to train five pre- and two post- doctoral trainees in an interdisciplinary program of molecular and genetic cancer epidemiology. In the last 5 years, this program has emphasized a multidisciplinary approach by providing instruction and mentorship in epidemiological methodology and the molecular aspects of cancer. In this continuation application, we will continue to focus our training program on molecular epidemiology of cancer with new directions on human microbiota, epigenome, post genome-wide gene-environment interactions, and integration of behavior and molecular epidemiology, in response to a remarkable progress in the development of new sophisticated high- throughput technologies which has enabled extensive applications of biologic markers in cancer epidemiology, etiology, and prognostic prediction. With continuous leadership, collaborative faculty, a well-defined curriculum, and interdisciplinary research environments, we will continue to provide trainees with opportunities to gain experience in both cancer-specific epidemiologic methods and molecular laboratory skills. This will allow trainees to utilize the knowledge of epidemiologic methods and molecular biology to elucidate genetic and epigenetic predisposition and susceptibility to cancer, to study the effects of environmental exposures on cancer risk, to describe the natural history of cancer among high-risk individuals with inherited genetic mutations, and to evaluate post-genome-wide gene-environment/gene-gene interactions on the risk of cancer. Special effort has been made, and will continue to be made, to recruit qualified predoc and postdoc candidates from URM backgrounds and with M.D. training to postdoc positions. In the last five years, we have filled most of predoc and postdoc positions. Since 2014, we have successfully recruited 5 highly qualified under- represented minority (URM) trainees into our program (23.8%), including three pre-doctoral and two post- doctoral trainees. In the last 10 years, our former and current pre-doctoral and post-doctoral trainees have published a total of 100 unique papers. Eleven pre-doctoral trainees have graduated and eight post-doctoral trainees have finished their training from our training program in 10 years. Graduates of the Molecular Epidemiology of Cancer Training Program currently hold academic and research positions at leading universities and research institutions. The Cancer Epidemiology Training Program has provided outstanding, rigorous interdisciplinary training in epidemiology, statistics, and biology since 1975, and we hope to continue this record of excellence in the future.

Public Health Relevance

The Molecular Epidemiology of Cancer Training Program emphasizes a multidisciplinary approach by providing instruction and mentoring to pre- and postdoctoral trainees in both epidemiological methodology and molecular genetic aspects of cancer. Eleven predoctoral trainees have graduated with Ph.D. degrees and eight postdoctoral trainees have finished their training and hold academic or research positions at leading universities and research institutions. In this continuation application, we will continue to focus our training program on molecular epidemiology of cancer with new directions on human microbiota, epigenome, post genome-wide gene-environment interactions, and integration of behavior and molecular epidemiology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009142-41
Application #
10025195
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1980-07-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
41
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Miles, Fayth L; Neuhouser, Marian L; Zhang, Zuo-Feng (2018) Concentrated sugars and incidence of prostate cancer in a prospective cohort. Br J Nutr 120:703-710
Stiemsma, Leah T; Michels, Karin B (2018) The Role of the Microbiome in the Developmental Origins of Health and Disease. Pediatrics 141:
Arrieta, Marie-Claire; Arévalo, Andrea; Stiemsma, Leah et al. (2018) Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J Allergy Clin Immunol 142:424-434.e10
Jin, Zi-Yi; Wallar, Gina; Zhou, Jin-Yi et al. (2018) Consumption of garlic and its interactions with tobacco smoking and alcohol drinking on esophageal cancer in a Chinese population. Eur J Cancer Prev :
Huang, Brian Z; Le Marchand, Loic; Haiman, Christopher A et al. (2018) Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study. Int J Cancer 142:2019-2027
Binder, Alexandra M; Stiemsma, Leah T; Keller, Kristen et al. (2018) Inverse association between estrogen receptor-? DNA methylation and breast composition in adolescent Chilean girls. Clin Epigenetics 10:122
Liu, Xing; Baecker, Aileen; Wu, Ming et al. (2018) Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population. Int J Cancer 142:1560-1567
Baecker, Aileen; Liu, Xing; La Vecchia, Carlo et al. (2018) Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev 27:205-212
Zhao, Jin-Kou; Wu, Ming; Kim, Claire H et al. (2017) Jiangsu Four Cancers Study: a large case-control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China. Eur J Cancer Prev 26:357-364
Meyers, Travis J; Chang, Shen-Chih; Chang, Po-Yin et al. (2017) Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers. Int J Cancer 140:2040-2050

Showing the most recent 10 out of 136 publications